Sorbact® supports Antimicrobial Stewardship

Respond to the rise of antimicrobial resistance with Sorbact®

The whole world has woken up to the challenge of antimicrobial resistance (AMR). Without effective tools for prevention and adequate treatment of infections, the number of people for whom treatment is failing will increase. Antimicrobial Stewardship (AMS) initiatives offer an opportunity to reduce the rate of AMR and Sorbact® dressings can form a valuable part of your AMS strategy.

Using Sorbact® as an approach to prevent and treat infection in both acute and hard-to-heal wounds supports AMS 1

This review article presents evidence that supports the integration of dressings that act in a physical manner as an alternative approach to prevent and/or treat infection in wounds. These dressings do not contribute to AMR and support AMS.1

Read more
Sorbact technology logo and Sorbact surface background

Sorbact® reduces the bioburden without antimicrobial agents

Based on natural processes and physical interactions, Sorbact® removes bacteria, irreversibly binding them to its surface to reduce bioburden and support wound healing. Sorbact® helps to take control of bacteria right from the start.

By this mode of action, Sorbact® dressings may lower the use of antibiotics and contribute to the management and prevention of wound infection.2 Development of bacterial or fungal resistance is not expected.

Read more about Sorbact® Technology

Sorbact® is effective against the Top 5 WHO pathogens

In vitro tests showed that Sorbact® DACC™-coated bacteria-binding wound dressing was able to inhibit the growth of all the WHO priority pathogens tested3:

  • Acinetobacter baumannii
  • Pseudomonas aeruginosa
  • Enterobacteriaceae (ESBL)
  • Enterococcus faecium (VRE)
  • Staphylococcus aureus (MRSA)
Read more

EWMA supports AMS

The overall aim of the AMS initiatives is to reduce inappropriate use of antibiotics by promoting, facilitating and teaching the use of antibiotic alternatives in wound management across all healthcare settings.

The European Wound Management Association (EWMA) supports AMS by providing practical recommendations for optimizing antimicrobial therapy for the treatment of wound infection. The evidence on Sorbact® aligns with EWMA recommendations and supports AMS in wound treatment.1

Visit The EWMA project


1.Rippon MG, Rogers AA, et al. 2021. Antimicrobial stewardship strategies in wound care: evidence to support the use of dialkylcarbamoyl chloride (DACC)-coated wound dressings. J Wound Care. 30(4):284–
2.Chadwick P and Ousey K. 2019. Bacterial-binding dressings in the management of wound healing and infection prevention: a narrative review. J Wound Care. 28(6)
3.Husmark J, Arvidsson A, et al. 2020. Antimicrobial effect of a DACC-coated bacteria-binding wound dressing against WHO pathogens. EWMA 2020.

Unsupported browser

This site probably won't work great in Internet Explorer. We generally only support the recent versions of major browsers like Chrome, Firefox, Safari and Edge.